UPDATE: Zenodo migration postponed to Oct 13 from 06:00-08:00 UTC. Read the announcement.

Poster Open Access

Anticancer Applications of Mesoporous Silica Nanoparticles

Minja Mladenović; Mirjana Mundžić; Aleksandra Pavlović; Nikola Knežević


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.5733889">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.5733889</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.5733889"/>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0003-2836-2700">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0003-2836-2700</dct:identifier>
        <foaf:name>Minja Mladenović</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>BioSense Institute</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Mirjana Mundžić</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>BioSense Institute</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0002-2946-7718">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0002-2946-7718</dct:identifier>
        <foaf:name>Aleksandra Pavlović</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>BioSense Institute</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0002-1563-7763">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0002-1563-7763</dct:identifier>
        <foaf:name>Nikola Knežević</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>BioSense Institute</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Anticancer Applications of Mesoporous Silica Nanoparticles</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2021</dct:issued>
    <dcat:keyword>Mesoporous silica nanoparticles (MSNs)</dcat:keyword>
    <dcat:keyword>nanocarriers</dcat:keyword>
    <dcat:keyword>drug delivery</dcat:keyword>
    <dcat:keyword>targeted therapy</dcat:keyword>
    <dcat:keyword>on-demand release</dcat:keyword>
    <frapo:isFundedBy rdf:resource="info:eu-repo/grantAgreement/EC/H2020/952259/"/>
    <schema:funder>
      <foaf:Organization>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.13039/100010661</dct:identifier>
        <foaf:name>European Commission</foaf:name>
      </foaf:Organization>
    </schema:funder>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2021-11-16</dct:issued>
    <dct:language rdf:resource="http://publications.europa.eu/resource/authority/language/ENG"/>
    <owl:sameAs rdf:resource="https://zenodo.org/record/5733889"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/5733889</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.5733888"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/biosense_institute"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/nanofacts"/>
    <dct:description>&lt;p&gt;The capabilities in applying mesoporous silica nanoparticles (MSN) for the construction of different types of nanosystems for simultaneous cancer therapy and diagnostics (theranostics) are widely known in the scientific literature. Their specific characteristics, such as high surface area (ca. 1000 m2/g), well-structured porosity, and versatile surface-functionalization possibilities allow devising a plethora of multifunctional nanostructures.&amp;nbsp;&lt;/p&gt; &lt;p&gt;In this context, our research team works on the synthesis of MSNs of different structures and their surface modification toward enabling active cancer-targeting. These MSNs are loaded with different cargo molecules which can serve different purposes, such as cancer treatment, imaging, or sensing cancer-specific environment and biomolecules. The process of cargo release can be also governed by employing externally applicable stimuli (e.g. light irradiation, magnetic field), or upon exposure to intratumoral conditions such as weakly acidic environment, the elevated concentration of glutathione, or in the presence of other cancer biomarkers. The control over this process allows the application of MSNs as unique facilitators in cancer therapy, imaging and sensing, with substantial benefits for enhancing the efficacy and precision of cancer treatment or for early cancer diagnosis.&lt;/p&gt;</dct:description>
    <dct:description>Acknowledgments: The authors acknowledge financial support of the Science Fund of the Republic of Serbia (PROMIS Grant No. 6060755) and the European Union's Horizon 2020 research and innovation programme (Grant agreement No. 952259).</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.5733889"/>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.5733889"/>
        <dcat:byteSize>1447244</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/5733889/files/7th Nano Today Conference finalno.pdf"/>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
  <foaf:Project rdf:about="info:eu-repo/grantAgreement/EC/H2020/952259/">
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">952259</dct:identifier>
    <dct:title>Networking Activities for Nanotechnology-Facilitated Cancer Theranostics</dct:title>
    <frapo:isAwardedBy>
      <foaf:Organization>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10.13039/100010661</dct:identifier>
        <foaf:name>European Commission</foaf:name>
      </foaf:Organization>
    </frapo:isAwardedBy>
  </foaf:Project>
</rdf:RDF>
110
50
views
downloads
All versions This version
Views 110110
Downloads 5050
Data volume 72.4 MB72.4 MB
Unique views 9292
Unique downloads 4848

Share

Cite as